Other examples of carriers of heterologous molecules mediated by a scFv are presented in studies by Wang et al. They generated immunoliposomes that were conjugated to a completely human anti-EGFR scFv that contained doxorubicin and vinorelbine; their results showed that this immunocomplex improved endocytosis and significantly decreased the drugs ́ therapeutic dosages in several cell lines of squamous cell carcinoma of the head and neck (SCCHN). This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.